AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Aug 22, 2025

3377_rpt_2025-08-22_9852f193-86d5-445e-816a-83783b143d52.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the "Market Abuse Regulation") and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Morten Enggaard Rasmussen
2. Reason for the notification
a) Position/status Executive Vice President
of People & Stakeholder Relations
b) Initial notification/ Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Novozymes A/S
b) LEI 529900T6WNZXD2R3JW38
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instrument
B-Shares
Identification code DK0060336014
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 390.00 716 shares
d) information
Aggregated
-
Aggregated volume
-
Price
Number of shares: 716
Average price, DKK: 390.00
Transaction value, DKK: 279,240.00
e) Date of transaction August 22, 2025
f) Place of the transaction Nasdaq Copenhagen

August 22, 2025

Company announcement no. 40

Contact information Investor relations

Tobias Bjorklund +45 3077 8682 [email protected]

Anders Enevoldsen +45 5350 1453 [email protected]

Katrine Spedtsberg Poulsen [email protected]

About Novonesis

Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.

Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark

Talk to a Data Expert

Have a question? We'll get back to you promptly.